Sol-Gel Synthesis of Ce(4-x) Sr(1+x) Fe(5-x) Zn (x) O(14+δ) [0 ≤ x ≤ 0.45] Superparamagnetic Oxide Systems and Its Magnetic, Dielectric, and Drug Delivery Properties

采用溶胶-凝胶法合成Ce(4-x)Sr(1+x)Fe(5-x)Zn(x)O(14+δ)[0 ≤ x ≤ 0.45]超顺磁性氧化物体系及其磁性、介电性能和药物递送性能

阅读:2

Abstract

In this work, we have successfully synthesized superparamagnetic nanocomposites, Ce(4-x) Sr(1+x) Fe(5-x) Zn (x) O(14+δ) (0 ≤ x ≤ 0.45) (CSFZ) (TA1-TA4: x = 0, 0.15, 0.30, and 0.45) via the Nitrate-citrate sol-gel method. X-ray diffraction studies show the formation of single-phase nanocomposites (NCs) and the average crystallite size is found to be 18 nm. Energy-dispersive X-ray spectroscopy analysis supports the formation of the desired product with the expected composition. The scanning electron microscopy image shows that the prepared samples are in spherical shape and highly porous in nature. Most of the particle sizes present in the image are in the range of 5-20 nm. The optical studies show an intense peak at 583 nm corresponding to the instantaneous existence of both Fe(2+) and Fe(3+) intervalence electronic charge transition bands. X-ray photoelectron spectra analysis confirms the presence of elements with their preferred oxidation state. The superparamagnetic nature of the prepared sample was confirmed by vibrating sample magnetometer analysis. Synthesized materials show a low saturate magnetic moment ranging from 0.3400 to 0.1075 emu/g. The coercivity and retentivity value of the synthesized NC is zero. The NCs show high encapsulation efficiency toward ciprofloxacin hydrochloride because of their unique structure and release the loaded drug molecules in a sustained manner up to 10 h at pH 7.4. Such NCs have high potential for use as multifunctional material in various fields such as optical properties, conductivity studies, dielectric, sensor, and drug delivery properties.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。